INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
Family of slain teen holds out hope for justice
The family of a slain Ben Davis student held a rally and prayer vigil Friday night as they continue to search for clues in their loved one's…
Remembering fallen Ofc. Rod Bradway 1 year later
Saturday marked one year since IMPD Officer Rod Bradway was killed in the line of duty while responding to a domestic disturbance at an…
Missing Noblesville teen found late Friday night
A missing Noblesville teen was found late Friday evening, police said.
Ind. Toll Road operator plans to file bankruptcy
The private operator of the Indiana Toll Road says it plans to file for bankruptcy Monday.
Cody Cousins sentenced to 65 years for attack
An Indiana man who admitted fatally stabbing and shooting a fellow Purdue University student inside a crowded classroom was sentenced Friday…
Neighbors welcome expanded Ten Point patrols
A local faith-based group that works to stop the violence announced plans to expand their patrols.